Acadian Asset Management
ADVM

Acadian Asset Management’s Adverum Biotechnologies ADVM Stock Holding History

Acadian Asset Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,902
Closed -$41K – 1733
2024
Q1 		$41K Buy
2,902
+108
+4% +$1.64K ﹤0.01% 1402
2023
Q4 		$20K Buy
+2,794
New +$25.5K ﹤0.01% 1587
2023
Q1 		– Sell
-12,921
Closed -$74K – 1716
2022
Q4 		$74K Buy
+12,921
New +$98K ﹤0.01% 1497
2021
Q3 		– Sell
-4,130
Closed -$144K – 1692
2021
Q2 		$144K Buy
+4,130
New +$222K ﹤0.01% 1536
2019
Q4 		– Sell
-1,596
Closed -$87K – 1827
2019
Q3 		$87K Sell
1,596
-918
-37% -$103K ﹤0.01% 1516
2019
Q2 		$299K Buy
2,514
+1,502
+148% +$124K ﹤0.01% 1131
2019
Q1 		$53K Buy
+1,012
New +$40.9K ﹤0.01% 1653
2018
Q2 		– Sell
-5,060
Closed -$293K – 1674
2018
Q1 		$293K Buy
+5,060
New +$315K ﹤0.01% 982

Other funds holding ADVM

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Acadian Asset Management's ADVM Position: Q2 2024 in Review

Acadian Asset Management sold out of Adverum Biotechnologies (ADVM) in Q2 2024, closing a stake of 2,902 shares — an estimated $41K sold.

Acadian Asset Management first reported a position in ADVM in Q1 2018 and held it in 8 quarters. The position peaked at $299K in Q2 2019. 68 funds tracked by Wall St. Rank hold ADVM as of Q2 2024.

  • Acadian Asset Management reported no remaining Adverum Biotechnologies position as of Q2 2024 after selling out during the quarter.
  • Acadian Asset Management sold 2,902 Adverum Biotechnologies shares in Q2 2024, an estimated $41K.
  • Acadian Asset Management first reported a position in Adverum Biotechnologies in Q1 2018 and held it in 8 quarters.
  • Acadian Asset Management's Adverum Biotechnologies position peaked at $299K in Q2 2019.
  • 68 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2024.

Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.